Vivify Health secured an undisclosed amount of money for its Series B funding from strategic investors – Laboratory Corporation of America Holdings (LabCorp) and Envision Healthcare Holdings (Envision). As part of the deal, LabCorp will receive a seat on Vivify’s Board of Directors.
The new funds will be used to accelerate development, delivery and broadening of Vivify’s patient engagement and remote patient monitoring solution designed to “span the population health continuum.” The company’s SaaS-based solution delivers the patient engagement services, including fully-managed kits to simplify engagement for the highest risk populations. The platform will now be extended to include remote care solutions geared to consumers’ own mobile devices (BYOD) that include technologies such as native apps, web apps, interactive voice response and text messaging for all risk-stratified layers.
LabCorp is a global leader in laboratory services, clinical trials and medical diagnostics, providing knowledge services to enhance patient care. Envision adds strategic value through their broad nationwide footprint of emergency and post-acute services, encompassing AMR, EmCare and Evolution Health. Through Evolution Health, an immediately scalable Medical Command Center is now in place nationwide, thereby providing simple turnkey remote care coordination options for Vivify customers.
The strategic investors in the round include Laboratory Corporation of America Holdings and Envision Healthcare Holdings.“Our combined solutions and services will allow us to expand our value beyond traditional fee-for-service to at-risk models, completing all stages of population health,” said Vivify CEO, Eric Rock. “We are thrilled to have multi-billion dollar organizations joining us in our mission to change the way healthcare is delivered.”
Vivify’s previous investors include Heritage Group and Ascension Health Ventures, whose limited partners encompass several of the largest health systems in the U.S.